NEW DELHI: The initial public offering (IPO) of KRM Ayurveda Limited is set to close today, January 23, 2026. The issue has witnessed healthy traction, crossing the 3x subscription mark as investors rush to bid before the window closes.

Operating in the booming Ayurvedic healthcare sector, the company’s ₹77.49 crore book-built issue has caught the eye of the market, particularly for its focus on chronic disease management and telemedicine.

Subscription Status: Retail Investors Lead the Charge

As of the latest update on Day 3, the IPO has been booked over 3 times overall. The Retail Individual Investors (RIIs) have shown significant interest, aggressively bidding for the minimum lot size.

Retail Category: Oversubscribed significantly.
Non-Institutional Investors (NII): Showing steady momentum.
QIBs: Expected to put in their bids in the final hours of the day.

GMP Update: What is the Premium?

Market observers note that the Grey Market Premium (GMP) for KRM Ayurveda is hovering in the range of ₹12 to ₹21 per share. This suggests a potential listing gain of approximately 10% to 15% over the upper price band of ₹135. While not an explosive premium, it indicates a stable and positive debut on the stock exchange.

Key Details at a Glance

Price Band: ₹128 to ₹135 per share.
Minimum Investment: Retail investors need to apply for a minimum of 2,000 shares (2 Lots), requiring an investment of ₹2,70,000.
Listing Platform: NSE SME.